Document 1yj92Lv1GEaE45deeRjpDERao

i EMPLOYEE RELATIONS DEPARTMENT MEDICAL DIVISION WILMINGTON, DELAWARE '9 4 November 8, 1966 TO: ALL PLANT PHYSICIANS FRCM: C. A. D'ALONZO, M.D. SXHI81T# Kafrhr-Qi OATS ** MASTROMMNI1 fORXWtOtJ. .riC. camnEa SHomwe fspofntss Dr. Zahn and I believe that the following may be of interest to you: 1. ASBESTOS - During the past year, a report was sent to you outlining the alleged Increasing incidence and concern over asbestosis, mesothelioma, and other related carcinomas in people with relatively minor exposure to asbestos. We are enclosing two more obviously controversial articles on this subject, presenting both sides of the question, for your consideration. In an effort to define our problem in this area and to develop the necessary preventive measures, where indicated, we are asking you to provide ua with the following information and to return it to us as soon aa possible. A. Sow many full-time Insulators do you have on your plant? B. How many employees do part-time insulating? (a) tfcat proportion of the time? C. List the (three) most prevalent type of Insulating material used 1 -2- E. Give che number of each of the following your plane haa experienced, if any: (a) Aabescosla 4b) Mesothelioma (c) Carcinoiaaa among insulator* F. List briefly any preventive meastirea or safety equipment required in your location when: (a) saving insulating materials (b) removing obsolete insulation (c) spraying insulating materials 2. PULMOKARY FUNCTION TEST - With the increasing incidence of chronic bronchitis, emphysema, lung cancer, etc., it is imperative chat we obtain as much information as possible on our employees' pulmonary statua to: A. guide ua in providing che neceaaary preventive measures, B. accumulate data for possible legal action in the future. In connection with this point, a pilot study is undervay at Chambers Work, using equipment and teats recommended by Dr. Tomashefaki, a specialist in pulmonary function.screehipg testa at the Ohio State University Medical Center, to determine our best plan of action. In the future, definite recommendations will be forthcoming concerning equipment, tests, and programs. It is suggested that you refrain from purchasing any ex pensive equipment or initiating any definitive program until such recommendations are received, ao to inaure a uniform coop any-wide policy. DUP 0 9 3 5 4 8 6 3 3. "SYMMETREL" - By now, I am hopeful that the Pharmaceutical Division of our X. & B. Department, has sent each of you a packet of information regarding "Symmetrel", Du Pone's new anti-influenza drug. I wish to stress to each of you that this drug is for the prevention of influenza, and not a cure. It appears to be effective primarily against the A2 strain. We bad a meeting today with their Marketing Division. You will each shortly receive a communication from Mr. Harry B. Roos, dealing with the central purchasing of this drug, and which will give your plant the wholesale rate. X am sura that the communication, which you will receive from Mr. Roos, will be self-explanatory and will arrive shortly. 4. AMERICAN BOARD OF OCCUPATIONAL MEDICINE - For those of you who may be preparing for the American Board of Occupational . Medicine, we wish to call your attention to the "First Western Insti tute on Occupational Medicine," from March 20-25,1967, at the Uni versity of CaUfornia, Berkeley, California. Dr. Tabershav has discussed this course with us and it is made as practical and complete as possibla with the view of preparing one for the Board Examinations. CAD'A/ag Enc.-2 oee ouuws